Hyderabad City-based Natco Pharma said that the Appeals Court in the US has rejected its marketing partner Alvogen’s appeal on Ibrutinib tablets. These are proposed generic equivalents to Imbruvica tablets made Pharmacyclics LLC. It is indicated in the treatment of cancer. Natco and its co-development and marketing partner Alvogen Pine Brook are assessing their option […]
Hyderabad: Hyderabad-based Natco Pharma reported a dip in its net profit for the quarter ended September 30, 2021 to Rs 65.1 crore as against Rs 203.90 crore in the same period last fiscal. The company registered a Rs 415.2 crore consolidated revenue during the quarter under review as against Rs 827.9 crore in the second […]
Hyderabad: A simple pill to treat Covid-19 positive patients! Yes, an anti-viral pill that could be easily prescribed and taken orally by Covid positive patients with a promise of cutting down the risk of hospitalisation and death by at least by half, could hit the Indian markets in the coming months. Multiple research institutions and […]
During the year, Natco spent Rs 349 crore on capital expenditure, a majority of which was used to enhance capabilities of their manufacturing facilities